Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pancrelipase for Postprandial Belching and Bloating
NCT00266721Phase 3Completed
- Sponsor
- Solvay
- Start
- Jan 2000
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in functional dyspepsia (FD) comparing Pancrelipase with Placebo (2 arms). Primary endpoints: Abdominal bloating severity, Abdominal pain severity and 1 more. Started Jan 2000; status: completed.
02
Drugs
pancrelipase
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on NCT00266721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00266721.